| Molecular formula | C28H35N5O4 |
|---|
| Molecular weight | 505.6 g/mol |
|---|
| Registered trials | 0 |
|---|
| PubChem CID | 216208 |
|---|
What Capromorelin Is
Capromorelin is a small molecule compound with the molecular formula C28H35N5O4 and a molecular weight of approximately 505.6. No approved human drug label data was available for this compound in the dataset reviewed. Without label information, details on indication, mechanism, or brand names cannot be summarized here.
Trial Footprint
No registered clinical trials were found in the dataset for capromorelin at the time of this review, and no sample trial records were available to describe. This summary reflects only the data on hand and should not be read as a complete account of all research activity involving this compound.
FAQ
Capromorelin is a small molecule compound identified in chemical databases with the molecular formula C28H35N5O4. No approved human drug label details were available in the data reviewed for this summary. As a result, specific information on its intended use or mechanism cannot be confirmed here.
The data reviewed did not include FDA label information for capromorelin, so approval status for human use cannot be confirmed from this source. Readers should consult official regulatory resources for definitive approval status.
The dataset reviewed showed no registered clinical trials for capromorelin at the time of retrieval. This does not necessarily mean no research exists, only that none was captured in this particular data source.
Capromorelin has the molecular formula C28H35N5O4 and a molecular weight of about 505.6. It is catalogued in PubChem, a public chemical information database, under a unique compound identifier.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication.
Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.
Sources: PubChem
Updated 2026-11-07